Interlinking Leukemia Cell Lines with Clinicopathological Therapeutics: Exploring Eugenol’s Anti-Cancer Potential for Leukemia and Its Types
Exploring Eugenol’s Anti-Cancer Potential for Leukemia and Its Types
DOI:
https://doi.org/10.54393/pjhs.v5i12.2536Keywords:
Eugenol, Leukemia, Apoptosis, Reactive Oxygen SpeciesAbstract
The clove oil contains a bioactive compound, eugenol, which holds promise as a therapeutic agent in cancer treatment, such as leukemia. Objectives: To represent eugenol’s clinicopathological potential, through the mechanism of action in leukemia cell lines and related mechanisms. Methods: Eugenol's anti-cancer effects are explored through pathways of apoptosis induction, cell cycle regulation and modulation of key oncogenic signalling pathways, including nuclear factor-kappa B, signal transducer and activator of transcription 3 and phosphatidylinositol 3-kinase/protein kinase B. One hundred twelve articles including those published between January 2013 to April 2024 were obtained using a comprehensive search after a conduction of a comprehensive search as directed by the PRISMA guidelines using databases such as PubMed, Google Scholar and, Semantic Scholar. Fifty-six studies that fulfilled the inclusion criteria were screened after which 42 studies on eugenol’s therapeutic effects in leukemia cells were found. 15 studies were finally included in the review table Results: It is found to induce reactive oxygen species and to inhibit tumor proliferation, as well as to improve the efficacy of conventional chemotherapeutics, according to research. The selective toxicity of eugenol toward leukemic cells with minimal effect on healthy peripheral blood cells is thus particularly appealing as a basis for use in the clinic. Furthermore, in vitro, in vivo and silico experiments show that eugenol, in combination with current cancer treatments, would better promote therapeutic outcomes. Conclusions: It was concluded that eugenol represents a novel therapeutic direction in leukemia and thus offers a compelling candidate for future drug development.
References
Chhikara BS and Parang K. Global Cancer Statistics 2022: The Trends Projection Analysis. Chemical Biology Letters. 2023 Jan; 10(1): 451-.
Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G et al. Global Burden of Hematologic Malignancies and Evolution Patterns Over the Past 30 Years. Blood Cancer Journal. 2023 May; 13(1): 82. doi: 10.1038/s41408-023-00853-3. DOI: https://doi.org/10.1038/s41408-023-00853-3
Azhagumeena C and Padma PR. A Review On the Therapeutic Role of Piper Betle, Syzygium Aromaticum and Their Bioactive Component Eugenol in Cancer Research. Israel Journal of Plant Sciences. 2021 Mar; 68(1-2): 48-59. doi: 10.1163/22238980-bja10024. DOI: https://doi.org/10.1163/22238980-bja10024
Yoon YE, Jung YJ, Lee SJ. The Anticancer Activities of Natural Terpenoids That Inhibit Both Melanoma and Non-Melanoma Skin Cancers. International Journal of Molecular Sciences. 2024 Apr; 25(8): 4423. doi: 10.3390/ijms25084423. DOI: https://doi.org/10.3390/ijms25084423
Zari AT, Zari TA, Hakeem KR. Anticancer properties of eugenol: A review. Molecules. 2021 Dec 6;26(23):7407. doi: 10.3390/molecules26237407. DOI: https://doi.org/10.3390/molecules26237407
Fathy M, Fawzy MA, Hintzsche H, Nikaido T, Dandekar T, Othman EM. Eugenol exerts apoptotic effect and modulates the sensitivity of HeLa cells to cisplatin and radiation. Molecules. 2019 Nov 3;24(21):3979. doi: 10.3390/molecules24213979. DOI: https://doi.org/10.3390/molecules24213979
Tang Y, Zhang H, Yang G, Fang C, Kong C, Tian L, Huang X. Pharmacokinetics studies of eugenol in Pacific white shrimp (Litopenaeus Vannamei) after immersion bath. BioMed Central Veterinary Research. 2022 Mar; 18(1): 122. doi: 10.1186/s12917-022-03145-3. DOI: https://doi.org/10.1186/s12917-022-03145-3
Ali A and Ali A. Pharmacological Perspectives of Eugenol in Modern Context. In Natural Pharmaceuticals and Green Microbial Technology. 2021 Feb: 31-47. doi: 10.1201/9781003003229-3. DOI: https://doi.org/10.1201/9781003003229-3
Zia S, Batool S, Shahid R. Could PCSK9 Be a New Therapeutic Target of Eugenol? In Vitro and in Silico Evaluation of Hypothesis. Medical Hypotheses. 2020 Mar; 136: 109513. doi: 10.1016/j.mehy.2019.109513. DOI: https://doi.org/10.1016/j.mehy.2019.109513
De Sa Junior PL, Câmara DA, Costa AS, Ruiz JL, Levy D, Azevedo RA et al. The Apoptotic Effect of Eugenol Envolves G2/M Phase Abrogation Accompanied by Mitochondrial Damage and Clastogenic Effect On Cancer Cell in Vitro. Phytomedicine. 2016 Jun; 23(7): 725-35. doi: 10.1016/j.phymed.2016.03.014. DOI: https://doi.org/10.1016/j.phymed.2016.03.014
Aziz O, Suleman A, Fatima Z, Yasin A, Nasir A, Ubaid M et al. Eugenol's Molecular Warfare against Human Leukemia K562 cells: In Vitro Insights to Chemotherapeutic Potentials. Journal of Health and Rehabilitation Research. 2024 Feb; 4(1): 943-9. doi: 10.61919/jhrr.v4i1.536. DOI: https://doi.org/10.61919/jhrr.v4i1.536
Binu P, Priya N, Abhilash S, Vineetha RC, Nair RH. Studies On Curative Efficacy of Monoterpene Eugenol On Anti-Leukemic Drug Arsenic Trioxide Induced Cardiotoxicity. Biomedicine and Pharmacotherapy. 2017 Jul; 91: 559-66. doi: 10.1016/j.biopha.2017.04.087. DOI: https://doi.org/10.1016/j.biopha.2017.04.087
Binu P, Soman R, Zakhariah Hisham O, Narayanan SP, Nair RH. Acute Promyelocytic Leukemia Drug–Arsenic Trioxide in the Presence of Eugenol Shows Differential Action On Leukemia Cells (HL-60) and Cardiomyocytes (H9c2)–Inference from NMR Study. Toxicology Mechanisms and Methods. 2021 Jul; 31(6): 457-66. doi: 10.1080/15376516.2021.1913685. DOI: https://doi.org/10.1080/15376516.2021.1913685
Khaliq HM, Bughio R, Nangdev P, Aziz O, Javed W. Integrating Eugenol with Intensive Care in Leukemia Patients: Exploration of Pro-Apoptotic Potential Against HL-60, Human Leukemia Cell Line. Anaesthesia, Pain and Intensive Care. 2024 Dec; 28(5): 871-5. doi: 10.35975/apic.v28i5.2491. DOI: https://doi.org/10.35975/apic.v28i5.2491
Azadi M, Alemi F, Sadeghi S, Mohammadi M, Rahimi NA, Mirzaie S et al. An Integrative in Silico Mathematical Modelling Study of the Anti-Cancer Effect of Clove Extract (Syzygium aromaticum) Combined with in Vitro Metabolomics Study Using 1HNMR Spectroscopy. Iranian Journal of Biotechnology. 2020 Jul; 18(3): e2336. doi: 10.30498/IJB.2020.141102.2336.
Choudhury P, Barua A, Roy A, Pattanayak R, Bhattacharyya M, Saha P. Eugenol Restricts Cancer Stem Cell Population by Degradation of Β-Catenin Via N-Terminal Ser37 Phosphorylation-An in Vivo and in Vitro Experimental Evaluation. Chemico-Biological Interactions. 2020 Jan; 316: 108938. doi: 10.1016/j.cbi.2020.108938. DOI: https://doi.org/10.1016/j.cbi.2020.108938
Teixeira C, Pereira RB, Pinto NF, Coelho CM, Fernandes MJ, Fortes AG et al. Eugenol β-amino/β-alkoxy Alcohols with Selective Anticancer Activity. International Journal of Molecular Sciences. 2022 Mar; 23(7): 3759. doi: 10.3390/ijms23073759. DOI: https://doi.org/10.3390/ijms23073759
Ulanowska M and Olas B. Biological Properties and Prospects for the Application of Eugenol: A Review. International Journal of Molecular Sciences. 2021 Apr; 22(7): 3671. doi: 10.3390/ijms22073671. DOI: https://doi.org/10.3390/ijms22073671
Jaganathan SK, Mondhe D, Wani ZA, Supriyanto E. Evaluation of Selected Honey and One of Its Phenolic Constituent Eugenol Against L1210 Lymphoid Leukemia. The Scientific World Journal. 2014; 2014(1): 912051. doi: 10.1155/2014/912051. DOI: https://doi.org/10.1155/2014/912051
Fadilah F, Yanuar A, Arsianti A, Andrajati R. Phenylpropanoids, Eugenol Scaffold, and Its Derivatives as Anticancer. Asian Journal of Pharmaceutical and Clinical Research. 2017 Mar: 41-6. doi: 10.22159/ajpcr.2017.v10i3.16071. DOI: https://doi.org/10.22159/ajpcr.2017.v10i3.16071
Abadi AV, Karimi E, Oskoueian E, Mohammad GR, Shafaei N. Chemical Investigation and Screening of Anti-Cancer Potential of Syzygium Aromaticum L. Bud (Clove) Essential Oil Nano-emulsion. 3 Biotech. 2022 Feb; 12(2): 49. doi: 10.1007/s13205-022-03117-2. DOI: https://doi.org/10.1007/s13205-022-03117-2
Ikezu UJ, Ugariogu SN, Ikpa CC, Adindu BC, Maduka TO. Insilico Determination of Anti-Cancer Activity of Phytochemical from Clove (Syzygium Aromaticum L) Seed. Journal of Chemical Society of Nigeria. 2023 Aug; 48(4). doi: 10.46602/jcsn.v48i4.911. DOI: https://doi.org/10.46602/jcsn.v48i4.911
Su Y, Wang Y, Yu Q, Wu Z, Zhang D, Yan C. Eugenol Suppresses VEGF-Dependent Angiogenesis by JAK2/STAT3 Pathway in Non-Small Cell Lung Cancer. Guidelines and Standards in Chinese Medicine. 2024 Jun; 2(2): 80-90. doi: 10.1097/gscm.0000000000000021. DOI: https://doi.org/10.1097/gscm.0000000000000021
Bispo JA, Pinheiro PS, Kobetz EK. Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harbor Perspectives in Medicine. 2020 Jun; 10(6): a034819. doi: 10.1101/cshperspect.a034819. DOI: https://doi.org/10.1101/cshperspect.a034819
Padhy I, Paul P, Sharma T, Banerjee S, Mondal A. Molecular Mechanisms of Action of Eugenol in Cancer: Recent Trends and Advancement. Life. 2022 Nov; 12(11): 1795. doi: 10.3390/life12111795. DOI: https://doi.org/10.3390/life12111795
Scioli MG, Storti G, D’Amico F, Rodríguez Guzmán R, Centofanti F, Doldo E et al. Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets. Journal of Clinical Medicine. 2020 Jun; 9(6): 1995. doi: 10.3390/jcm9061995. DOI: https://doi.org/10.3390/jcm9061995
Patra S, Pradhan B, Nayak R, Behera C, Panda KC, Das S et al. Apoptosis and Autophagy Modulating Dietary Phytochemicals in Cancer Therapeutics: Current Evidence and Future Perspectives. Phyto-therapy Research. 2021 Aug; 35(8): 4194-214. doi: 10.1002/ptr.7082. DOI: https://doi.org/10.1002/ptr.7082
Begum SN, Ray AS, Rahaman CH. A Comprehensive and Systematic Review On Potential Anticancer Activities of Eugenol: From Pre-Clinical Evidence to Molecular Mechanisms of Action. Phytomedicine. 2022 Dec; 107: 154456. doi: 10.1016/j.phymed.2022.154456. DOI: https://doi.org/10.1016/j.phymed.2022.154456
Yarian F, Yousefpoor Y, Hatami S, Zarenezhad E, Peisepar E, Alipanah H et al. Comparison Effects of Alginate Nanoparticles Containing Syzygium Aromaticum Essential Oil and Eugenol On Apoptotic Regulator Genes and Viability of A-375 and MCF-7 Cancer Cell Lines. Bio-Nano-Science. 2023 Sep; 13(3): 911-9. doi: 10.1007/s12668-023-01121-1. DOI: https://doi.org/10.1007/s12668-023-01121-1
Alwan S, Hatem T, Abid H. Molecular Mechanisms of Eugenol as an Antitumour Bioactive Compound: A Comprehensive Review. In BIO Web of Conferences. 2024; 125: 03007. doi: 10.1051/bioconf/202412503007. DOI: https://doi.org/10.1051/bioconf/202412503007
Nazreen S, Elbehairi SE, Malebari AM, Alghamdi N, Alshehri RF, Shati AA et al. New Natural Eugenol Derivatives as Antiproliferative Agents: Synthesis, Biological Evaluation, and Computational Studies. American Chemical Society Omega. 2023 May; 8(21): 18811-22. doi: 10.1021/acsomega.3c00933. DOI: https://doi.org/10.1021/acsomega.3c00933
Li Z, Veeraraghavan VP, Mohan SK, Bolla SR, Lakshmanan H, Kumaran S et al. Apoptotic Induction and Anti-Metastatic Activity of Eugenol Encapsulated Chitosan Nanopolymer On Rat Glioma C6 Cells Via Alleviating the MMP Signalling Pathway. Journal of Photochemistry and Photobiology B: Biology. 2020 Jan; 203: 111773. doi: 10.1016/j.jphotobiol.2019.111773. DOI: https://doi.org/10.1016/j.jphotobiol.2019.111773
Djaldetti M. Eugenol-A Reminder of Its Carcinopreventive Properties. International Journal of Clinical Infectious Diseases. 2022;1(1). doi:10.31579/2834-5177/004.
Kapoor S, Kutre S, Joshi S, Goswami A, Singh A, Teja PK et al. Modulation of Tumour Pyruvate Kinase M2 and Suppression of Cancer Cell Proliferation Using Natural and Synthetic Antioxidants. Journal of Molecular Structure. 2024 Jun; 1305: 137751. doi: 10.1016/j.molstruc.2024.137751. DOI: https://doi.org/10.1016/j.molstruc.2024.137751
Jaganathan SK and Supriyanto E. Ant proliferative and Molecular Mechanism of Eugenol-Induced Apoptosis in Cancer Cells. Molecules. 2012 May; 17(6): 6290-304. doi: 10.3390/molecules17066290 DOI: https://doi.org/10.3390/molecules17066290
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
